These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18985556)

  • 21. Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy.
    Bot P; Semmekrot BA; van der Stappen J
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F153. PubMed ID: 16492956
    [No Abstract]   [Full Text] [Related]  

  • 22. Neonatal adverse reactions after in utero exposure to selective serotonin reuptake inhibitors: still controversial.
    Beaulac-Baillargeon L; Boucher N
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):855-6; author reply 856. PubMed ID: 16894088
    [No Abstract]   [Full Text] [Related]  

  • 23. Poor neonatal adaptation in term infant. Fluoxetine toxicity.
    Kwon P; Lefkowitz W
    Pediatr Ann; 2008 Mar; 37(3):131-3. PubMed ID: 18411855
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of third trimester fluoxetine exposure on the newborn.
    Goldstein DJ
    J Clin Psychopharmacol; 1995 Dec; 15(6):417-20. PubMed ID: 8748430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
    Cissoko H; Swortfiguer D; Giraudeau B; Jonville-Béra AP; Autret-Leca E
    Arch Pediatr; 2005 Jul; 12(7):1081-4. PubMed ID: 15964522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA; Mourad L; ter Haar J; Egberts AC
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome.
    Jordan AE; Jackson GL; Deardorff D; Shivakumar G; McIntire DD; Dashe JS
    J Matern Fetal Neonatal Med; 2008 Oct; 21(10):745-51. PubMed ID: 19012191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective serotonin reuptake inhibitor syndrome: precipitated by concomitant clozapine?
    Lu ML; Lane HY; Chang WH
    J Clin Psychopharmacol; 1999 Aug; 19(4):386-7. PubMed ID: 10440475
    [No Abstract]   [Full Text] [Related]  

  • 31. Serotonin syndrome associated with fluoxetine and olanzapine.
    Chopra P; Ng C; Schweitzer I
    World J Biol Psychiatry; 2004 Apr; 5(2):114-5. PubMed ID: 15179671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can fluoxetine alone cause serotonin syndrome in adolescents?
    Ghanizadeh A; Ghanizadeh M; Seifoori M
    Psychopharmacol Bull; 2008; 41(4):76-9. PubMed ID: 19015631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum.
    Bonetto N; Santelli L; Battistin L; Cagnin A
    Cephalalgia; 2007 Dec; 27(12):1421-3. PubMed ID: 17868285
    [No Abstract]   [Full Text] [Related]  

  • 34. Neonatal paroxetine withdrawal syndrome.
    Stiskal JA; Kulin N; Koren G; Ho T; Ito S
    Arch Dis Child Fetal Neonatal Ed; 2001 Mar; 84(2):F134-5. PubMed ID: 11207233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine.
    Murray KL; Miller KM; Pearson DL
    J Perinatol; 2007 Aug; 27(8):517-8. PubMed ID: 17653218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: case report and literature review].
    Agut-Quijano T; Martínez-Nadal S; Elizari-Saco MJ; Sala-Castellví P; Vila-Cerén C; Raspall-Torrent F
    Rev Neurol; 2006 Jun 1-15; 42(11):660-2. PubMed ID: 16736401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal abstinence syndrome.
    Jansson LM; Velez M
    Curr Opin Pediatr; 2012 Apr; 24(2):252-8. PubMed ID: 22227786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptans and serotonin syndrome.
    Evans RW
    Cephalalgia; 2008 May; 28(5):573-4; author reply 574-5. PubMed ID: 18355351
    [No Abstract]   [Full Text] [Related]  

  • 39. A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy.
    Boucher N; Bairam A; Beaulac-Baillargeon L
    J Clin Psychopharmacol; 2008 Jun; 28(3):334-9. PubMed ID: 18480693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Birth outcomes in pregnant women taking fluoxetine.
    Chambers CD; Johnson KA; Dick LM; Felix RJ; Jones KL
    N Engl J Med; 1996 Oct; 335(14):1010-5. PubMed ID: 8793924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.